RANI THERAPEUTICS HOLDINGS-A (RANI) Stock Earnings & Estimates
USA - NASDAQ:RANI - US7530181004 - Common Stock
0.48 USD
+0 (+0.17%)
0.4704 USD
-0.01 (-2%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 1.028M | 189.72K -81.54% | -100.00% | 61.227M | 76.667M 25.22% | 166.74M 117.49% | 311.02M 86.53% | 458.47M 47.41% | |||
| EBITDA YoY % growth | -62.9M -23.09% | -65.277M -3.78% | -48.572M 25.59% | -53.857M -10.88% | -58.051M -7.79% | -60.954M -5.00% | -33.603M 44.87% | 501.84K 101.49% | 112.16M 22,249.75% | 313.38M 179.40% | 529.44M 68.95% | |
| EBIT YoY % growth | -63.45M -22.97% | -66.099M -4.17% | -49.6M 24.96% | -44.168M 10.95% | -48.116M -8.94% | -51.051M -6.10% | -12.739M 75.05% | -6.239M 51.02% | 60.724M 1,073.24% | 175.15M 188.44% | 298.73M 70.56% | |
| Operating Margin | N/A | N/A | -4,824.90% | -23,280.38% | N/A | N/A | -20.81% | -8.14% | 36.42% | 56.31% | 65.16% | |
| EPS YoY % growth | -1.28 26.33% | -1.33 -3.91% | -1.06 20.30% | -0.55 48.04% | -0.41 25.00% | -0.39 6.17% | -0.38 2.63% | -0.26 32.43% | 0.10 140.00% | 0.69 580.00% | 1.22 76.47% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.11 53.25% | -0.10 62.22% | -0.11 49.00% | -0.12 32.00% | -0.12 -9.09% | -0.11 -10.00% |
| Revenue Q2Q % growth | -100.00% | -100.00% | ||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -10.384M 12.00% | -10.825M 3.73% | -10.71M 10.85% | -12.036M -14.57% | -12.75M -22.79% | -13.77M -27.21% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.18 30.77% | -0.20 | 0.02 | 9.50% |
| Q1 2025 Q2Q % growth | -0.22 24.14% | -0.21 | -0.01 | -6.08% |
| Q4 2024 Q2Q % growth | -0.27 | -0.25 | -0.02 | -7.31% |
| Q3 2024 Q2Q % growth | -0.24 33.33% | -0.26 | 0.02 | 8.50% |
| Q2 2024 Q2Q % growth | -0.26 29.73% | -0.32 | 0.06 | 18.43% |
| Q1 2024 Q2Q % growth | -0.29 12.12% | -0.21 | -0.08 | -39.83% |
| Q4 2023 Q2Q % growth | -0.27 22.86% | -0.32 | 0.05 | 15.05% |
| Q3 2023 Q2Q % growth | -0.36 -9.09% | -0.37 | 0.01 | 3.48% |
| Q2 2023 Q2Q % growth | -0.37 -19.35% | -0.41 | 0.04 | 10.28% |
| Q1 2023 Q2Q % growth | -0.33 -13.79% | -0.42 | 0.09 | 21.76% |
| Q4 2022 Q2Q % growth | -0.35 -29.63% | -0.35 | 0.00 | 1.40% |
| Q3 2022 Q2Q % growth | -0.33 -175.00% | -0.48 | 0.15 | 30.87% |
| Q2 2022 Q2Q % growth | -0.31 -158.33% | -0.59 | 0.28 | 47.37% |
| Q1 2022 Q2Q % growth | -0.29 | -0.67 | 0.38 | 56.92% |
| Q4 2021 Q2Q % growth | -0.27 | -0.50 | 0.23 | 46.52% |
| Q3 2021 Q2Q % growth | -0.12 | -0.18 | 0.06 | 34.64% |
| Q2 2021 Q2Q % growth | -0.12 | -0.18 | 0.06 | 33.16% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | 110.497K | -110.497K | -100.00% | |
| Q3 2022 Q2Q % growth | 132.6K | -132.6K | -100.00% | |
| Q2 2022 Q2Q % growth | -100.00% | 132.6K | -132.6K | -100.00% |
| Q1 2022 Q2Q % growth | -100.00% | 331.5K | -331.5K | -100.00% |
| Q4 2021 Q2Q % growth | -100.00% | 165.75K | -165.75K | -100.00% |
| Q3 2021 Q2Q % growth | -100.00% | 293.25K | -293.25K | -100.00% |
| Q2 2021 Q2Q % growth | 1.96M 3,166.67% | 499.8K | 1.46M | 292.16% |
| Q1 2021 Q2Q % growth | 760K 850.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 43.59% | -4.85% | 33.33% |
| Revenue | N/A | N/A | 0% | 100% |